{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:00:47Z","timestamp":1791176447294,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.nbd.2005.01.022","type":"journal-article","created":{"date-parts":[[2005,3,19]],"date-time":"2005-03-19T23:18:26Z","timestamp":1111274306000},"page":"407-418","source":"Crossref","is-referenced-by-count":105,"title":["A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting"],"prefix":"10.1016","volume":"19","author":[{"given":"James K.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Garrity-Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Boulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2005.01.022_bib1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/sj.gt.3301773","article-title":"Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle","volume":"9","author":"Abadie","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib2","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1089\/104303400750038435","article-title":"Gene Therapy for amyotrophic lateral sclerosis and other motor neuron diseases","volume":"11","author":"Alisky","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1515\/CCLM.2001.055","article-title":"Neurotrophic factor therapy\u2014Prospects and problems","volume":"39","author":"Apfel","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.nbd.2005.01.022_bib4","first-page":"241","article-title":"Neurotrophic factors and amyotrophic lateral sclerosis","volume":"68","author":"Askanas","year":"1995","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2005.01.022_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm0396-299","article-title":"Toward cell-targeting gene therapy vectors: selection of cell binding from random peptide-presenting phage libraries","volume":"2","author":"Barry","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2005.01.022_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","article-title":"(Phase III) A controlled trial of recombinant methionyl human BDNF in ALS","volume":"52","author":"BDNF, s.g.","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2005.01.022_bib7","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1097\/00001756-200108080-00048","article-title":"Delayed application of IGF-1 and GDNF can rescue already injured postnatal motor neurons","volume":"12","author":"Bilak","year":"2001","journal-title":"NeuroReport, JID"},{"key":"10.1016\/j.nbd.2005.01.022_bib8","doi-asserted-by":"crossref","unstructured":"Blazes, D., Lawler, J., Lazarus, A., 2002. When biotoxins are tools of terror. Early recognition of intentional poisoning can attenuate effects. Postgrad. Med. 112, 89\u201392, 95\u201386, 98","DOI":"10.3810\/pgm.2002.08.1278"},{"key":"10.1016\/j.nbd.2005.01.022_bib9","first-page":"155","article-title":"Clinical characteristics and management of ALS","volume":"21","author":"Borasio","year":"2001","journal-title":"Semin. Neurosci."},{"key":"10.1016\/j.nbd.2005.01.022_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","article-title":"A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGFI Study Group","volume":"51","author":"Borasio","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2005.01.022_bib11","first-page":"S110","article-title":"Adeno-associated viral gene expression in the adult rat spinal cord following remote vector delivery","volume":"1","author":"Boulis","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.nbd.2003.08.025","article-title":"Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery","volume":"14","author":"Boulis","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2005.01.022_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1227\/01.NEU.0000044459.24519.3E","article-title":"Intraneural colchicine inhibition of adenoviral and adeno-associated viral vector remote spinal cord gene delivery","volume":"52","author":"Boulis","year":"2003","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2005.01.022_bib14","first-page":"971","article-title":"A phase I\/II strudy of recombinant human brain-derived neurotrophic factor in patients with amyotrophic lateral sclerosis {abstract}","author":"Bradley","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2005.01.022_bib15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.nbd.2005.01.022_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(98)00169-3","article-title":"Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS","volume":"793","author":"Chamberlin","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2005.01.022_bib17","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1212\/WNL.46.5.1244","article-title":"A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis","volume":"46","author":"CNTF","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2005.01.022_bib18","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1073\/pnas.94.17.9400","article-title":"Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system","volume":"94","author":"Coen","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2005.01.022_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0896-6273(03)00397-0","article-title":"NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals","volume":"39","author":"Delcroix","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2005.01.022_bib20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archneur.1988.00520290094020","article-title":"Motoneuron uptake from the circulation of the binding fragment of tetanus toxin","volume":"45","author":"Fishman","year":"1988","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2005.01.022_bib21","doi-asserted-by":"crossref","first-page":"32274","DOI":"10.1074\/jbc.M103285200","article-title":"The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin","volume":"276","author":"Fotinou","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2005.01.022_bib22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/71021","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2005.01.022_bib23","series-title":"Viral vectors","first-page":"1","article-title":"Herpes simplex virus as a gene-delivery vector for the central nervous system","author":"Glorioso","year":"1995"},{"key":"10.1016\/j.nbd.2005.01.022_bib24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1006\/mthe.2001.0345","article-title":"Incorporation of tumor-targeting peptides into adeno-associated virus capsids","volume":"3","author":"Grifman","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm0497-429","article-title":"Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors","volume":"3","author":"Haase","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2005.01.022_bib26","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1016\/S0021-9258(18)82109-3","article-title":"Characterization of the receptor binding\u2013binding domain of tetanus toxin","volume":"268","author":"Halpern","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2005.01.022_bib27","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1046\/j.1471-4159.2000.0741941.x","article-title":"Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons","volume":"74","author":"Herreros","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2005.01.022_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/0264-6021:3470199","article-title":"C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor","volume":"347","author":"Herreros","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2005.01.022_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneumeth.2004.03.013","article-title":"Identification of plypeptides with selective affinity to intact mouse cerebellar granule neurons from a random peptide-presenting phage library","volume":"138","author":"Hou","year":"2004","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2005.01.022_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.micro.53.1.551","article-title":"Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins","volume":"53","author":"Johnson","year":"1999","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.nbd.2005.01.022_bib31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/mthe.2001.0520","article-title":"Targeted retrograde gene delivery for neuronal protection","volume":"5","author":"Kaspar","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","article-title":"Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model","volume":"301","author":"Kaspar","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2005.01.022_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnen\/62.4.340","article-title":"Neurotrophins and neurodegenerative disease: receptors stuck in traffic?","volume":"62","author":"Kruttgen","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2005.01.022_bib34","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","article-title":"Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I Study Group","volume":"49","author":"Lai","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2005.01.022_bib35","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.ymthe.2004.06.417","article-title":"Neuronal membrane specific binding peptides isolated via phage display biopanning against trisialogangliosides","volume":"9","author":"Liu","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/sj.gt.3302046","article-title":"Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver","volume":"10","author":"Loiler","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib37","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1021\/bi020291j","article-title":"Identification of a binding site for ganglioside on the receptor binding domain of tetanus toxin","volume":"41","author":"Louch","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2005.01.022_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-0102(02)00195-5","article-title":"Intramuscular injection of AAV-GDNF results in expression of transgenic GDNF, and its delivery to spinal motorneurons by retrograde transport","volume":"45","author":"Lu","year":"2003","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2005.01.022_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00429-002-0233-1","article-title":"Targeting functional subtypes of spinal motorneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors","volume":"205","author":"Martinov","year":"2002","journal-title":"Anat. Embryol."},{"key":"10.1016\/j.nbd.2005.01.022_bib40","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/hmg\/10.19.2109","article-title":"Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery","volume":"10","author":"Mazarakis","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2005.01.022_bib41","series-title":"In botulinum neurotoxin and tetanus toxin","first-page":"95","article-title":"Cell surface receptors for protein toxins","author":"Middlebrook","year":"1989"},{"key":"10.1016\/j.nbd.2005.01.022_bib42","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ana.410390215","article-title":"A placebo-controlled trial of recombinant human ciliary neurotrophic (rhCNTF) factor in amyotrophic lateral sclerosis","volume":"39","author":"Miller","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2005.01.022_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0014-5793(94)00449-8","article-title":"Bacterial toxins penetrate cells via a four-step mechanism","volume":"346","author":"Montecucco","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2005.01.022_bib44","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.CIR.102.2.231","article-title":"Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display","volume":"102","author":"Nicklin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.nbd.2005.01.022_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/mthe.2001.0424","article-title":"Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells","volume":"4","author":"Nicklin","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canlet.2003.08.011","article-title":"Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents","volume":"202","author":"Oyama","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.nbd.2005.01.022_bib47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0166-0934(02)00117-9","article-title":"Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression","volume":"105","author":"Rohr","year":"2002","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.nbd.2005.01.022_bib48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/(SICI)1097-4598(199904)22:4<460::AID-MUS6>3.0.CO;2-L","article-title":"Elucidation of muscle-binding peptides by phage display screening","volume":"22","author":"Samoylova","year":"1999","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2005.01.022_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-5728(02)00071-1","article-title":"Targeting peptides for microglia identified via phage display","volume":"127","author":"Samoylova","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2005.01.022_bib50","doi-asserted-by":"crossref","first-page":"30380","DOI":"10.1074\/jbc.272.48.30380","article-title":"Identification of ganglioside recognition domain of tetanus toxin using a novel ganglioside photoaffinity ligand","volume":"272","author":"Shapiro","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2005.01.022_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1525-0016(03)00042-X","article-title":"RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism","volume":"7","author":"Shi","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib52","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1365-2958.2000.02091.x","article-title":"Analysis of mutants of tetanus toxin Hc fragment: ganglioside binding, cell binding and retrograde axonal transport properties","volume":"37","author":"Sinha","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.nbd.2005.01.022_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(75)90604-6","article-title":"Comparison between the retrograda axonla transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons","volume":"99","author":"Stoeckel","year":"1975","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2005.01.022_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-5793(01)02273-6","article-title":"Tyrosine-1290 of tetanus neurotoxin plays a key role in its binding to gangliosides and functional binding to neurones","volume":"493","author":"Sutton","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2005.01.022_bib55","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2004.03.001","article-title":"IGF-I prevents glutamate-induced motor neuron programmed cell death","volume":"16","author":"Vincent","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2005.01.022_bib56","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","article-title":"Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis","volume":"22","author":"Wang","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2005.01.022_bib57","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1128\/JVI.78.12.6595-6609.2004","article-title":"Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus","volume":"78","author":"Warrington","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2005.01.022_bib58","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1016\/S1525-0016(16)41334-1","article-title":"Targeting of adenoviral and adeno-associated viral vectors selectively to endothelial cells using novel 12-mer peptides isolated by phage display","volume":"7","author":"White","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2005.01.022_bib59","doi-asserted-by":"crossref","first-page":"25173","DOI":"10.1074\/jbc.274.35.25173","article-title":"Neuronal sensitivity to tetanus toxin requires gangliosides","volume":"274","author":"Williamson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2005.01.022_bib60","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1128\/JVI.74.18.8635-8647.2000","article-title":"Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism","volume":"74","author":"Wu","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2005.01.022_bib61","doi-asserted-by":"crossref","first-page":"10405","DOI":"10.1073\/pnas.162250899","article-title":"The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy","volume":"99","author":"Xie","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2005.01.022_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0304-3835(01)00575-4","article-title":"Neuroblastoma tumor cell-binding peptides identified through random peptide phage display","volume":"171","author":"Zhang","year":"2001","journal-title":"Cancer Lett."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610500032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096999610500032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T01:37:31Z","timestamp":1625621851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096999610500032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S096999610500032X"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2005.01.022","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}